• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday

    3/3/23 11:40:36 AM ET
    $AI
    $ARDX
    $COMP
    $DM
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AI alert in real time by email

    U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

    • Ardelyx, Inc. (NASDAQ:ARDX) gained 28% to $3.70 after the company reported better-than-expected Q4 sales results.
    • C3.ai, Inc. (NYSE:AI) shares surged 24.3% to $26.48 after the company reported better-than-expected Q3 results and issued strong guidance.
    • Samsara Inc. (NYSE:IOT) rose 21.7% to $20.55 after the company reported better-than-expected Q4 results and issued strong guidance.
    • Velo3D, Inc. (NYSE:VLD) jumped 20.5% to $3.4094 after the company reported better-than-expected Q4 adjusted EPS and sales results.
    • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) rose 19% to $2.5950 after the company reported Q4 financial results.
    • Gaotu Techedu Inc. (NYSE:GOTU) gained 17.5% to $5.16.
    • Veritone, Inc. (NASDAQ:VERI) jumped 16.7% to $7.42 after the company reported Q4 financial results.
    • LivePerson, Inc. (NASDAQ:LPSN) surged 16.2% to $11.19 after Craig-Hallum upgraded the stock from Hold to Buy and raised its price target from $13 to $15.
    • DermTech, Inc. (NASDAQ:DMTK) rose 15.3% to $4.38 following strong quarterly results.
    • Reading International, Inc. (NASDAQ:RDIB) climbed 13.6% to $22.75.
    • Genelux Corporation (NASDAQ:GNLX) rose 13.6% to $18.60.
    • Xponential Fitness, Inc. (NYSE:XPOF) gained 12.9% to $28.57 after the company reported better-than-expected Q4 EPS and sales results.
    • Compass, Inc. (NYSE:COMP) rose 12.6% to $3.40. Compass recently reported worse-than-expected Q4 results and issued weak Q1 guidance.
    • Zai Lab Limited (NASDAQ:ZLAB) jumped 12.1% to $41.42.
    • TuSimple Holdings Inc. (NYSE:TSP) gained 12.1% to $2.0291.
    • HPX Corp. (NYSE:HPX) shares climbed 12% to $19.50. The company’s shareholders recently approved the proposed business combination with Emergencia Participacoes.
    • MiMedx Group, Inc. (NASDAQ:MDXG) gained 11% to $4.34.
    • Desktop Metal, Inc. (NYSE:DM) jumped 10.3% to $2.2509. Desktop Metal reported better-than-expected Q4 sales results and issued guidance.
    • PagSeguro Digital Ltd. (NYSE:PAGS) rose 9.9% to $9.31 after reporting a 35% surge in its Q4 net profit.
    • ECARX Holdings Inc. (NASDAQ:ECX) gained 9.9% to $4.90.
    • Integral Ad Science Holding Corp. (NASDAQ:IAS) rose 9.4% to $11.70 after the company reported better-than-expected Q4 EPS and sales results.
    • Stagwell Inc. (NASDAQ:STGW) jumped 9.4% to $8.30 after the company reported better-than-expected Q4 adjusted EPS and sales results.
    • Tuya Inc. (NYSE:TUYA) gained 9.2% to $1.7050.
    • New Oriental Education & Technology Group Inc. (NYSE:EDU) jumped 7.7% to $45.89.

    Check This Out: Around $16M Bet On This Consumer Cyclical Stock? Check Out These 3 Stocks Insiders Are Buying

    Get the next $AI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AI
    $ARDX
    $COMP
    $DM

    CompanyDatePrice TargetRatingAnalyst
    Samsara Inc.
    $IOT
    3/6/2026$40.00 → $44.00Outperform
    BMO Capital Markets
    Xponential Fitness Inc.
    $XPOF
    2/27/2026$7.00Buy → Neutral
    Roth Capital
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    Samsara Inc.
    $IOT
    2/25/2026$50.00 → $40.00Outperform
    BMO Capital Markets
    MiMedx Group Inc
    $MDXG
    2/23/2026$10.00Mkt Outperform
    Citizens
    Samsara Inc.
    $IOT
    2/11/2026$36.00Buy
    Goldman
    New Oriental Education & Technology Group Inc. Sponsored ADR r
    $EDU
    1/28/2026Hold → Buy
    HSBC Securities
    Compass Inc.
    $COMP
    1/27/2026$14.00Neutral
    Goldman
    More analyst ratings

    $AI
    $ARDX
    $COMP
    $DM
    SEC Filings

    View All

    Xponential Fitness Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Xponential Fitness, Inc. (0001802156) (Filer)

    3/10/26 4:26:48 PM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Stagwell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Stagwell Inc (0000876883) (Filer)

    3/10/26 7:18:17 AM ET
    $STGW
    Advertising
    Consumer Discretionary

    SEC Form 10-K filed by Lexicon Pharmaceuticals Inc.

    10-K - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)

    3/5/26 4:50:45 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AI
    $ARDX
    $COMP
    $DM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Veritone Updates Date of Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    Veritone, Inc. (NASDAQ:VERI) ("Veritone" or the "Company"), a leader in building enterprise AI and data solutions, today announced that the Company will now hold a conference call on Thursday, March 26, 2026, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time), to discuss its results for the fourth quarter and full year 2025, provide an update on the business and conduct a question-and-answer session. The updated earnings release date is required primarily to allow additional time to finalize the Company's accounting treatment related to certain commercial transactions that transpired in the fourth quarter of 2025. To participate, please join the conference call or live audio webcast links

    3/10/26 5:38:00 PM ET
    $VERI
    EDP Services
    Technology

    Xponential Fitness, Inc. Announces CFO Transition

    Robert Julian Appointed Interim Chief Financial Officer Company Reaffirms Fiscal Year 2026 Outlook Xponential Fitness, Inc. (NYSE:XPOF) ("Xponential" or the "Company"), one of the leading global franchisors of boutique health and wellness brands, today announced that John Meloun, Chief Financial Officer, has separated from the Company effective March 9, 2026. Robert Julian has been appointed interim Chief Financial Officer, effective March 16, 2026. Mr. Julian brings more than 30 years of financial leadership experience, having previously served as the Chief Financial Officer of TheRealReal, Inc. (NASDAQ:REAL), Callaway Golf (NYSE:ELY), Executive Vice President and Chief Financial Offic

    3/10/26 4:10:00 PM ET
    $REAL
    $SPWH
    $XPOF
    Other Specialty Stores
    Consumer Discretionary
    Services-Misc. Amusement & Recreation
    Recreational Games/Products/Toys

    OriginPoint Reaffirms Longstanding Commitment to Agents with Enhancements to OneDown Mortgage Program

    Enhanced incentives boost the lender-paid grant and add a temporary buydown option to help agents win and closeCHICAGO, March 10, 2026 /PRNewswire/ -- OriginPoint, Rate's joint venture mortgage platform built alongside leading real estate brokerages, today announced enhancements to its OneDown 1% Down Mortgage Program, increasing the lender-paid grant and introducing a new lender-paid temporary buydown option. The enhancements further strengthen OriginPoint's long-term commitment to real estate agents and their buyers nationwide. Originally rolled out in August 2025, OneDown was

    3/10/26 9:00:00 AM ET
    $COMP
    EDP Services
    Technology

    $AI
    $ARDX
    $COMP
    $DM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Samsara with a new price target

    BMO Capital Markets reiterated coverage of Samsara with a rating of Outperform and set a new price target of $44.00 from $40.00 previously

    3/6/26 8:42:04 AM ET
    $IOT
    EDP Services
    Technology

    Xponential Fitness downgraded by Roth Capital with a new price target

    Roth Capital downgraded Xponential Fitness from Buy to Neutral and set a new price target of $7.00

    2/27/26 8:34:02 AM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    C3.ai downgraded by Citizens

    Citizens downgraded C3.ai from Mkt Outperform to Mkt Perform

    2/26/26 7:10:22 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    $AI
    $ARDX
    $COMP
    $DM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $AI
    $ARDX
    $COMP
    $DM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    Director Debbane Raymond bought $2,980 worth of shares (2,000 units at $1.49), increasing direct ownership by 0.11% to 1,906,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/27/26 8:33:21 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $147,000 worth of shares (100,000 units at $1.47), increasing direct ownership by 6% to 1,904,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/25/26 7:00:27 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AI
    $ARDX
    $COMP
    $DM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Stagwell Inc.

    4 - Stagwell Inc (0000876883) (Issuer)

    3/10/26 7:03:19 PM ET
    $STGW
    Advertising
    Consumer Discretionary

    SEC Form 4 filed by Stagwell Inc.

    4 - Stagwell Inc (0000876883) (Issuer)

    3/10/26 7:01:55 PM ET
    $STGW
    Advertising
    Consumer Discretionary

    SEC Form 4 filed by Stagwell Inc.

    4 - Stagwell Inc (0000876883) (Issuer)

    3/10/26 7:01:14 PM ET
    $STGW
    Advertising
    Consumer Discretionary

    $AI
    $ARDX
    $COMP
    $DM
    Financials

    Live finance-specific insights

    View All

    Veritone Updates Date of Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    Veritone, Inc. (NASDAQ:VERI) ("Veritone" or the "Company"), a leader in building enterprise AI and data solutions, today announced that the Company will now hold a conference call on Thursday, March 26, 2026, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time), to discuss its results for the fourth quarter and full year 2025, provide an update on the business and conduct a question-and-answer session. The updated earnings release date is required primarily to allow additional time to finalize the Company's accounting treatment related to certain commercial transactions that transpired in the fourth quarter of 2025. To participate, please join the conference call or live audio webcast links

    3/10/26 5:38:00 PM ET
    $VERI
    EDP Services
    Technology

    Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates

    Pivotal sotagliflozin milestones on schedule including resubmission of NDA in T1D and enrollment of SONATA study for HCM  Positive End-of-Phase 2 meeting with FDA for pilavapadin confirms Phase 3 readiness and supports ongoing partnership discussions Strengthened financial position with more than $100 million in additional cash from capital raise and Novo Nordisk milestone payment Conference call and webcast at 8:30 am ET   THE WOODLANDS, Texas, March 05, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), today reported financial results for the three months and year ended December 31, 2025, and provided an update on key corporate milestones and accomplishments.  "

    3/5/26 6:59:00 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

    BEIJING, March 5, 2026 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE:GOTU) ("Gaotu" or the "Company"), a leading technology-driven education company in China focused on enabling lifelong learning through AI-powered solutions, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Highlights[1]Net revenues were RMB1,685.3 million, increased by 21.4% from RMB1,388.6 million in the same period of 2024.Gross billings[2] were RMB2,573.7 million, increased by 19.1% from RMB2,160.2 million in the same period of 2024.Loss from operations was RMB118.0 million, compared with loss from operations of RMB149.3 million in the same per

    3/5/26 1:13:00 AM ET
    $GOTU
    Other Consumer Services
    Real Estate

    $AI
    $ARDX
    $COMP
    $DM
    Leadership Updates

    Live Leadership Updates

    View All

    Coldwell Banker Real Estate Announces 2025 Year-End Award Winners

    The brand recognizes the top affiliated sales professionals, teams, offices and companies who have demonstrated exceptional performance across multiple sales categories in the past year MADISON, N.J., Jan. 29, 2026 /PRNewswire/ -- Coldwell Banker Real Estate LLC today announced the 2025 recipients of its annual year-end awards, recognizing top‑ranking performers whose achievements exemplify the highest standards of excellence across the Coldwell Banker® network. "Each year, the dedication of the Coldwell Banker real estate professionals, teams, and offices elevates the standar

    1/29/26 10:00:00 AM ET
    $COMP
    EDP Services
    Technology

    Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer

    WESTLAKE VILLAGE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) --  Genelux Corporation (NASDAQ:GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Jason Litten, M.D., as Chief Medical Officer, effective January 2, 2026. Dr. Litten will oversee all clinical development and medical strategy as the company advances Olvi-Vec through multiple upcoming pivotal milestones. "We are excited to welcome Jason, who is widely recognized for his strategic approach to clinical development and commitment to improving patient outcomes," said Thomas Zindrick, President, CEO, and Chairman of the Board. "He brings extensive experience in oncology drug development of innovati

    1/2/26 8:00:00 AM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IAS APPOINTS MELISSA FURZE AS HEAD OF DATA SCIENCE

    Former LinkedIn executive to scale IAS's data science and AI capabilities worldwide NEW YORK, Dec. 22, 2025 /PRNewswire/ -- Integral Ad Science (NASDAQ:IAS), a leading global media measurement and optimization platform, today announced that Melissa Furze joined the company as Head of Data Science at IAS reporting to the Chief Technology Officer. Melissa will lead the company's global data science, AI, and analytics strategy, partnering closely with product, engineering, and the commercial teams to accelerate innovation, strengthen protection and performance capabilities, and deliver trusted, data-driven outcomes for advertisers and publishers worldwide.

    12/22/25 8:00:00 AM ET
    $IAS
    Computer Software: Programming Data Processing
    Technology

    $AI
    $ARDX
    $COMP
    $DM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Samsara Inc.

    SC 13D/A - Samsara Inc. (0001642896) (Subject)

    12/11/24 9:27:25 PM ET
    $IOT
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Tuya Inc.

    SC 13G - Tuya Inc. (0001829118) (Subject)

    12/4/24 9:00:55 PM ET
    $TUYA
    Computer Software: Prepackaged Software
    Technology

    $AI
    $ARDX
    $COMP
    $DM
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Air Transport Services Group Inc on Jun 7 Indicate?

    Recently, on June 7, 2024, Michael L Berger, a significant figure at Air Transport Services Group Inc, made a notable insider purchase. Berger bought $49,830 worth of shares, acquiring 3,996 units at a price of $12.47 per share. This transaction increased his direct ownership by 4% to 103,705 units as reported in the SEC Form 4 here. Examining other insider actions within the company can sometimes reveal intriguing patterns that might offer insights for investors. Looking back at previous transactions, we see a series of insider activities at Air Transport Services Group Inc: In March 2024, Dominick Jeffrey A. filed an SEC Form 4, indicating a notable transaction date in which actions were

    6/10/24 12:35:45 AM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care